Not Signed In -
CRP |
|
|
Clinical Trial: CRP On Radiobiological and Clinical Study On Virally-Induced Cancers Response to Radiotherapy
This study is not yet open for patient recruitment.
|
Purpose
To study clinical effects of two/four HDR brachytherapy applications and teletherapy with or without weekly Cisplatin in cervix cancer.
| Condition | Intervention | Phase |
|---|---|---|
| Cervix Cancer | Procedure: Radiotherapy alone and Radiotherapy with Cisplatin | Phase III |
MedlinePlus related topics: Cervical Cancer
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Cervix Cancer
Exclusion Criteria:
- unable to give an informed consent
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00122772
Branislav Jeremic, M.D., Ph.D. +43-1-2600 Ext. 21666 B.Jeremic@iaea.org
Study chairs or principal investigators
Branislav Jeremic, M.D., Ph.D., Study Director, International Atomic Energy Agency (IAEA)
More Information
Study ID Numbers: E33024
Record last reviewed: July 2005
Last Updated: July 25, 2005
Record first received: July 21, 2005
ClinicalTrials.gov Identifier: NCT00122772
Health Authority: United Nations: International Atomic Energy Agency
ClinicalTrials.gov processed this record on 2005-07-26
Record last reviewed: July 2005
Last Updated: July 25, 2005
Record first received: July 21, 2005
ClinicalTrials.gov Identifier: NCT00122772
Health Authority: United Nations: International Atomic Energy Agency
ClinicalTrials.gov processed this record on 2005-07-26
email this page
print this page
bookmark this page
feedback on this page
